SOURCE: Somatic Systems, Inc.

December 13, 2007 11:57 ET

Somatic Systems, Inc. Launches Shareholder Question and Answer Forum

NORTHAMPTON, MA--(Marketwire - December 13, 2007) - Somatic Systems, Inc. (PINKSHEETS: SMAS), a leader in the field of pain management, today released a letter to shareholders from Chief Executive Officer Steven Aronstein. The letter is a response to shareholder questions the company has received in the past month, and provides detailed information about some of the company's business activities and growth plans, including planned locations for nationwide rollout of clinics and training classes. The CEO answers direct questions about Somatic Systems' professional training programs and financial aid, efforts with the military and VA hospitals, and the forthcoming books and television programs about the company's proprietary Clinical Somatics pain management system. The letter also confirms the company is planning to up-list to the OTC Bulletin Boards in 2008.

The letter is featured in the Investor Relations section of the company's web site, at http://somatics.org/investors/letters/2007/12/11.

These questions and answers can also be found at http://somatics.org/investors/qa. This special new section of Somatic Systems' web site, called Shareholder Questions, was launched by the company today, and will continue to feature direct answers to questions the company receives from shareholders. Furthermore, shareholders and anyone else interested in getting up-to-date direct information about the company can now register with the web site and receive briefings when these Shareholder Questions are updated or new questions are answered.

To obtain these company briefings, interested parties can go to http://somatics.org/user and click on the "Create New Account" button and fill out the form.

"We are always looking for more and better ways to communicate with the shareholder community, so they can see as clearly as our customers do all the ways in which Somatic Systems offers such a great opportunity," stated Somatic Systems CEO Steven Aronstein. "We hope our new Questions and Answers section helps shareholders do diligent research to make sound decisions to invest in Somatic Systems."

About Somatic Systems, Inc.

Somatic Systems is the worldwide center for Clinical Somatics™, the ground-breaking drug-free, non-surgical approach to pain relief. This proprietary system uses natural, non-invasive movement techniques -- conducted through one-hour hands-on sessions, therapeutic exercise classes, and home exercises lasting as little as 5 minutes a day -- to relieve pain and limitation resulting from accident, trauma and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis and more. Clinical Somatics™ also provides performance gains and injury prevention for casual and professional athletes.

Somatic Systems is pursuing a 3-part growth strategy, consisting of a nationwide rollout of pain management Somatics Clinics; increased production and distribution of therapeutic videos, books, and other retail self-help Somatics Products; and expanded Somatics Training Programs to supply Clinic practitioners serving medical and orthopedic professionals and institutional and corporate programs. The company operates a suite of web sites offering Somatics information, products, resources, and opportunities, at www.somatics.org.

Safe Harbor Act: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact Information